Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010282 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
NCT01010282: Completed NA study, sponsored by Allergan.
NCT01010282 is a NA study that has completed, run by Allergan. The registered enrollment target is 288 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01010282, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
Study Summary
This study will evaluate the safety, efficacy, and acceptability of two artificial tears compared to a currently available artificial tear in subjects with dry eye.
Primary Outcome
Change from baseline in SESoD score at day 90. The SESoD is a 5-point scale where 0 equals no dryness, 1 equals trace dryness, 2 equals mild dryness, 3 equals moderate dryness, and 4 equals severe dryness. A negative number change from baseline indicates a decrease (improvement) in the symptom of dryness.
Interventions
- DRUG Glycerin and Polysorbate 80 based artificial tear
- DRUG Formulation 1: Carboxymethylcellulose sodium, glycerin and Polysorbate 80, based artificial tear
- DRUG Formulation 2: Carboxymethylcellulose sodium, glycerin, and Polysorbate 80 based artificial tear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-04 |
| Phase | NA |
What the finished NCT01010282 record still lists
NCT01010282 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which Glycerin and Polysorbate 80 based artificial tear is the first listed.
NCT01010282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01010282 about?
NCT01010282 is a clinical study titled "Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects". This study will evaluate the safety, efficacy, and acceptability of two artificial tears compared to a currently available artificial tear in subjects with dry eye.
What is the current status of trial NCT01010282?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2009-11. Estimated completion is 2010-04.
What interventions are being tested in trial NCT01010282?
The interventions under investigation include: Glycerin and Polysorbate 80 based artificial tear (DRUG), Formulation 1: Carboxymethylcellulose sodium, glycerin and Polysorbate 80, based artificial tear (DRUG), Formulation 2: Carboxymethylcellulose sodium, glycerin, and Polysorbate 80 based artificial tear (DRUG).
Who is sponsoring clinical trial NCT01010282?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01010282's enrollment target sits among peer trials
288 376th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia